Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.
D000328:Adult; D000803:Angiotensin I / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors; D001794:Blood Pressure / Q000187:drug effects*; D002216:Captopril / Q000494:pharmacology*; D003517:Cyclopentanes / Q000494:pharmacology*; D004151:Dipeptides / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004656:Enalapril; D006801:Humans; D011392:Proline / Q000031:analogs & derivatives*
D000806:Angiotensin-Converting Enzyme Inhibitors; D003517:Cyclopentanes; D004151:Dipeptides; D004656:Enalapril; C034144:pivalopril; D000803:Angiotensin I; D011392:Proline; D002216:Captopril